← Back to directory

Séamus O’Reilly

Researcher Next ID · RN-040451

Researcher · Biochemistry, Genetics and Molecular Biology

Royal College of Surgeons in Ireland

Dublin, Ireland

Accepting doctoral researchersFunding unknown
Works count
429
Citation count
8,625
H-index
39
i10-index
96

Research interests

Biochemistry, Genetics and Molecular Biology
Economics, Econometrics and Finance
Medicine
Breast Cancer Treatment Studies
Cancer Treatment and Pharmacology
Economic and Financial Impacts of Cancer
Advanced Breast Cancer Therapies
Colorectal Cancer Treatments and Studies

Publications

  • Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

    ˜The œLancet. Gastroenterology & hepatology · 2023 · 10.1016/s2468-1253(23)00243-1

  • Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

    ˜The œLancet. Gastroenterology & hepatology · 2023 · 10.1016/s2468-1253(23)00243-1

  • The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme

    Journal of Neuro-Oncology · 2013 · 10.1007/s11060-013-1164-9

  • The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme

    Journal of Neuro-Oncology · 2013 · 10.1007/s11060-013-1164-9

  • Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08

    Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.30.0855

  • Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer

    Journal of Clinical Oncology · 2009 · https://doi.org/10.1200/jco.2009.21.9220

  • Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation

    Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.1.145

  • A Prospective Pharmacologic Evaluation of Age-Related Toxicity of Adjuvant Chemotherapy in Women with Breast Cancer

    Cancer Investigation · 2000 · 10.3109/07357900009012191

  • Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

    Blood · 1994 · 10.1182/blood.v83.5.1193.1193

  • Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction.

    PubMed · 1994

  • Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy [see comments]

    Blood · 1994 · 10.1182/blood.v83.5.1193.1193

  • Effect of daily etidronate on the osteolysis of multiple myeloma.

    Journal of Clinical Oncology · 1991 · 10.1200/jco.1991.9.8.1397

  • Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

    Journal of Clinical Oncology · 1989 · https://doi.org/10.1200/jco.1989.7.11.1748

Current projects

    No projects listed.